Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial.

Cohort Studies Cost-Benefit Analysis Cross-Sectional Studies Dementia / therapy Humans Psychomotor Agitation / therapy Quality of Life
Alzheimer’s disease Current Controlled Trials ISRCTN82288852 health economic evaluation institutional care/residential care intervention long-term care person-centred care practice development psychosocial interventions

Journal

Aging & mental health
ISSN: 1364-6915
Titre abrégé: Aging Ment Health
Pays: England
ID NLM: 9705773

Informations de publication

Date de publication:
08 2021
Historique:
pubmed: 14 4 2020
medline: 7 8 2021
entrez: 14 4 2020
Statut: ppublish

Résumé

Agitation is common and problematic in care home residents with dementia. This study investigated the (cost)effectiveness of Dementia Care Mapping™ (DCM) for reducing agitation in this population. Pragmatic, cluster randomised controlled trial with cost-effectiveness analysis in 50 care homes, follow-up at 6 and 16 months and stratified randomisation to intervention ( DCM was not superior to control on any outcomes (cross-sectional sample No benefits of DCM were evidenced. Low intervention dose indicates standard care homes may be insufficiently resourced to implement DCM. Alternative models of implementation, or other approaches to reducing agitation should be considered.

Identifiants

DOI: 10.1080/13607863.2020.1745144 PMID: 32279541
pubmed: 32279541
doi: 10.1080/13607863.2020.1745144
doi:

Banques de données

ISRCTN
['ISRCTN82288852']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1410-1423

Subventions

Organisme : Department of Health
ID : 11/15/13
Pays : United Kingdom

Auteurs

Claire A Surr (CA)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.
ORCID: 0000-0002-4312-6661

Ivana Holloway (I)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Rebecca E A Walwyn (REA)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Alys W Griffiths (AW)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.

David Meads (D)

Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

Adam Martin (A)

Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

Rachael Kelley (R)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.

Clive Ballard (C)

Medical School, University of Exeter, Exeter, UK.

Jane Fossey (J)

Psychological Services, Oxford Health NHS Foundation Trust, Oxford, UK.

Natasha Burnley (N)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.
ORCID: 0000-0003-4174-4084

Lynn Chenoweth (L)

Centre for Healthy Brain Ageing, University of New South Wales, Sydney, Australia.

Byron Creese (B)

Medical School, University of Exeter, Exeter, UK.

Murna Downs (M)

Centre for Applied Dementia Studies, University of Bradford, Bradford, UK.

Lucy Garrod (L)

Psychological Services, Oxford Health NHS Foundation Trust, Oxford, UK.

Elizabeth H Graham (EH)

Academic Unit of Elderly Care and Rehabilitation, Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.

Amanda Lilley-Kelly (A)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Joanne McDermid (J)

Liaison Psychiatry Services, Wolfson Centre for Age Related Diseases, Kings College London, London, UK.

Vicki McLellan (V)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Holly Millard (H)

Psychological Services, Oxford Health NHS Foundation Trust, Oxford, UK.

Devon Perfect (D)

Psychological Services, Oxford Health NHS Foundation Trust, Oxford, UK.

Louise Robinson (L)

Institute of Health and Society, Newcastle University, Newcastle upon Tyne, UK.

Olivia Robinson (O)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.

Emily Shoesmith (E)

Centre for Dementia Research, School of Health and Community Studies, Leeds Beckett University, Leeds, UK.

Najma Siddiqi (N)

Department of Health Sciences, Hull York Medical School, University of York, York, UK.
Bradford District Care NHS Foundation Trust, Bradford, UK.

Graham Stokes (G)

Memory Care, HC-One, Darlington, UK.

Daphne Wallace (D)

Centre for Applied Dementia Studies, University of Bradford, Bradford, UK.

Amanda J Farrin (AJ)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Effectiveness of Dementia Care Mapping™ to...
questionsmedicales.fr › Organisations et économie des soins de santé › Économie › Coûts et analyse des coûts › Analyse coût-bénéfice › Effectiveness of Dementia Care Mapping™ to...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Effectiveness of Dementia Care Mapping™ to...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Effectiveness of Dementia Care Mapping™ to...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Effectiveness of Dementia Care Mapping™ to...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Manifestations neurocomportementales › Troubles psychomoteurs › Agitation psychomotrice › Effectiveness of Dementia Care Mapping™ to...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Effectiveness of Dementia Care Mapping™ to...